Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 334

1.

Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.

Calanna S, Scicali R, Di Pino A, Knop FK, Piro S, Rabuazzo AM, Purrello F.

Nutr Metab Cardiovasc Dis. 2014 Jun;24(6):670-6. doi: 10.1016/j.numecd.2014.01.013. Epub 2014 Jan 29.

PMID:
24656139
2.

Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.

Calanna S, Scicali R, Di Pino A, Knop FK, Piro S, Rabuazzo AM, Purrello F.

Acta Diabetol. 2014 Aug;51(4):567-75. doi: 10.1007/s00592-014-0555-5. Epub 2014 Jan 18.

PMID:
24442427
3.

Serum fetuin-A concentration predicts glycaemic outcomes in people with prediabetes: a prospective study from eastern India.

Dutta D, Mondal SA, Kumar M, Hasanoor Reza AH, Biswas D, Singh P, Chakrabarti S, Mukhopadhyay S.

Diabet Med. 2014 Dec;31(12):1594-9. doi: 10.1111/dme.12539. Epub 2014 Jul 23.

PMID:
24975463
4.

Prevalence of Prediabetes and Undiagnosed Diabetes in Canada (2007-2011) According to Fasting Plasma Glucose and HbA1c Screening Criteria.

Rosella LC, Lebenbaum M, Fitzpatrick T, Zuk A, Booth GL.

Diabetes Care. 2015 Jul;38(7):1299-305. doi: 10.2337/dc14-2474. Epub 2015 Apr 7.

PMID:
25852207
5.

Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes.

Shao N, Kuang HY, Hao M, Gao XY, Lin WJ, Zou W.

Diabetes Metab Res Rev. 2014 Sep;30(6):521-9. doi: 10.1002/dmrr.2561.

PMID:
24823873
6.

Association of prediabetes by fasting glucose and/or haemoglobin A1c levels with subclinical atherosclerosis and impaired renal function: observations from the Dallas Heart Study.

Xing FY, Neeland IJ, Gore MO, Ayers CR, Paixao AR, Turer AT, Berry JD, Khera A, de Lemos JA, McGuire DK.

Diab Vasc Dis Res. 2014 Jan;11(1):11-8. doi: 10.1177/1479164113514239.

PMID:
24344119
7.

Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic control.

Tan CE, Chew LS, Chio LF, Tai ES, Lim HS, Lim SC, Jayakumar L, Eng HK, Packard CJ.

Diabetes Res Clin Pract. 2001 Feb;51(2):107-14.

PMID:
11165690
8.

Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease.

Esteghamati A, Noshad S, Khalilzadeh O, Khalili M, Zandieh A, Nakhjavani M.

Metab Syndr Relat Disord. 2011 Apr;9(2):111-7. doi: 10.1089/met.2010.0066. Epub 2010 Nov 20.

PMID:
21091060
9.

Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c.

Zagami RM, Di Pino A, Urbano F, Piro S, Purrello F, Rabuazzo AM.

Atherosclerosis. 2015 Dec;243(2):395-401. doi: 10.1016/j.atherosclerosis.2015.09.038. Epub 2015 Oct 9.

PMID:
26520892
10.

Non-HDL-cholesterol in an adolescent diabetes population.

Kuryan RE, Jacobson MS, Frank GR.

J Clin Lipidol. 2014 Mar-Apr;8(2):194-8. doi: 10.1016/j.jacl.2013.12.006. Epub 2013 Dec 17.

PMID:
24636179
11.
12.

Evaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population.

Kharroubi AT, Darwish HM, Abu Al-Halaweh AI, Khammash UM.

PLoS One. 2014 Feb 5;9(2):e88123. doi: 10.1371/journal.pone.0088123. eCollection 2014.

13.

Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.

Grattagliano I, Ubaldi E, Napoli L, Marulli CF, Nebiacolombo C, Cottone C, Portincasa P.

Ann Hepatol. 2013 Jan-Feb;12(1):70-7.

14.

Diagnostic efficiency of hemoglobin A1c for newly diagnosed diabetes and prediabetes in community-based Chinese adults aged 40 years or older.

Liang K, Sun Y, Li WJ, Zhang XP, Li CQ, Yang WF, Ma ZQ, Ma AX, Zheng HZ, Song J, Lin P, Hou XG, Chen L.

Diabetes Technol Ther. 2014 Dec;16(12):853-7. doi: 10.1089/dia.2014.0157. Epub 2014 Jul 11.

15.

Diabetes mellitus is associated with early chronic venous disorder of the lower extremities in Chinese patients with cardiometabolic risk factors.

Zhong J, Chen J, Zhao ZG, He HB, Yan ZC, Liu DY, Zhu ZM, Ni YX.

Diabetes Metab Res Rev. 2014 Sep;30(6):505-12. doi: 10.1002/dmrr.2551.

PMID:
24700718
16.

Hepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study.

Leon-Acuña A, Alcala-Diaz JF, Delgado-Lista J, Torres-Peña JD, Lopez-Moreno J, Camargo A, Garcia-Rios A, Marin C, Gomez-Delgado F, Caballero J, Van-Ommen B, Malagon MM, Perez-Martinez P, Lopez-Miranda J.

Cardiovasc Diabetol. 2016 Apr 19;15:68. doi: 10.1186/s12933-016-0380-y.

17.

Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.

Lv WS, Sun RX, Gao YY, Wen JP, Pan RF, Li L, Wang J, Xian YX, Cao CX, Zheng M.

World J Gastroenterol. 2013 May 28;19(20):3134-42. doi: 10.3748/wjg.v19.i20.3134.

19.

Evaluation of serum lipid profile, body mass index, and waistline in Chinese patients with type 2 diabetes mellitus.

Cui R, Qi Z, Zhou L, Li Z, Li Q, Zhang J.

Clin Interv Aging. 2016 Apr 18;11:445-52. doi: 10.2147/CIA.S104803. eCollection 2016.

20.

Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.

Sobhonslidsuk A, Pulsombat A, Kaewdoung P, Petraksa S.

Asian Pac J Cancer Prev. 2015;16(5):1789-94.

Supplemental Content

Support Center